Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive Cutaneous Melanoma, ICEMAN Trial

This clinical trial compares the effect of a narrow surgical excision (removal) to a wide excision for the treatment of adults with invasive cutaneous melanoma. Currently the standard of care is to take wide margins (boarder of healthy tissue surrounding the melanoma) when removing melanoma. Narrow margin excision removes a smaller amount of healthy tissue when surgically removing the melanoma. Narrow margin excision may be effective in removing the melanoma while also reducing surgical complications and improving quality of life for adults with invasive cutaneous melanoma.

Trial Details

NCT ID
NCT06673095
Phase
NA
Sponsor
OHSU Knight Cancer Institute
Status
RECRUITING
Cancer Type
Melanoma
Interventions
  • Biospecimen Collection
  • Excision
  • Survey Administration
Locations (sample)
  • Davis, California, United States|38.54491,-121.74052
  • Lexington, Kentucky, United States|37.98869,-84.47772
  • Ann Arbor, Michigan, United States|42.27756,-83.74088
  • Cleveland, Ohio, United States|41.4995,-81.69541
  • Portland, Oregon, United States|45.52345,-122.67621

Key Eligibility Criteria

  • Participants or legally authorized representatives (LAR) must provide written informed consent before any study-specific procedures or intervention…
  • Age ≥ 18 years; all biological gender identities and racial/ethnic groups will be included
  • Participants must have histologically confirmed primary cutaneous melanoma. Acral melanomas are eligible.
  • Participants must have one of the following:

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Melanoma Trials on Trialify →